Total Payments
$5,187
2024 Payments
$249.12
Companies
35
Transactions
339
Medicare Patients
10,858
Medicare Billing
$580,201
Payment Breakdown by Category
Food & Beverage$5,182 (99.9%)
Education$5.11 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,182 | 338 | 99.9% |
| Education | $5.11 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $637.08 | 55 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $504.96 | 21 | $0 (2024) |
| AbbVie Inc. | $473.68 | 31 | $0 (2023) |
| Merck Sharp & Dohme LLC | $426.23 | 33 | $0 (2022) |
| Amgen Inc. | $414.50 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $339.14 | 28 | $0 (2022) |
| PFIZER INC. | $314.05 | 14 | $0 (2023) |
| Allergan, Inc. | $244.15 | 15 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $202.49 | 14 | $0 (2021) |
| Lilly USA, LLC | $194.39 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $249.12 | 13 | Radius Health, Inc. ($64.21) |
| 2023 | $598.82 | 31 | PFIZER INC. ($243.99) |
| 2022 | $574.19 | 37 | Novo Nordisk Inc ($129.24) |
| 2021 | $916.84 | 60 | AbbVie Inc. ($283.65) |
| 2020 | $713.71 | 49 | Novo Nordisk Inc ($144.93) |
| 2019 | $827.57 | 56 | Mylan Specialty L.P. ($141.38) |
| 2018 | $348.76 | 25 | Merck Sharp & Dohme Corporation ($62.57) |
| 2017 | $958.25 | 68 | AstraZeneca Pharmaceuticals LP ($174.96) |
All Payment Transactions
339 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Biological | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Insulin Pump | ||||||
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Endocrinology | ||||||
| 02/16/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Endocrinology | ||||||
| 02/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Inflammation | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 01/12/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Endocrinology | ||||||
| 12/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Gastroenterology | ||||||
| 11/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Inflammation | ||||||
| 11/07/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/28/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Inflammation | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Diabetes | ||||||
| 08/14/2023 | PFIZER INC. | COMIRNATY (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: VACCINES | ||||||
| 08/10/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,580 | 4,566 | $427,580 | $147,406 |
| 2022 | 41 | 2,749 | 4,663 | $424,029 | $142,793 |
| 2021 | 48 | 2,919 | 4,801 | $451,826 | $161,031 |
| 2020 | 40 | 2,610 | 4,487 | $420,646 | $128,971 |
Total Patients
10,858
Total Services
18,517
Medicare Billing
$580,201
Procedure Codes
165
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 820 | $196,800 | $68,360 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 124 | 124 | $19,220 | $15,553 | 80.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 115 | $17,250 | $6,797 | 39.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 65 | 67 | $4,690 | $4,596 | 98.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 31 | $12,400 | $4,179 | 33.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 221 | 462 | $4,620 | $3,881 | 84.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 64 | $9,600 | $3,873 | 40.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 171 | 231 | $12,012 | $3,802 | 31.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 214 | 365 | $25,550 | $3,767 | 14.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 103 | 128 | $10,496 | $3,655 | 34.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 173 | 235 | $17,625 | $3,057 | 17.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 64 | 285 | $14,820 | $2,645 | 17.8% |
| 77067 | Screening mammography | Office | 2023 | 29 | 29 | $8,700 | $2,571 | 29.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 211 | 336 | $8,400 | $2,557 | 30.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 71 | 73 | $2,190 | $2,146 | 98.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 119 | 143 | $11,154 | $2,084 | 18.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 29 | 30 | $4,500 | $1,881 | 41.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 24 | 59 | $3,835 | $1,819 | 47.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 82 | 82 | $2,050 | $1,465 | 71.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,120 | $1,267 | 24.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 19 | 20 | $3,200 | $1,190 | 37.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 58 | 103 | $3,605 | $961.52 | 26.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 22 | $1,870 | $848.61 | 45.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 25 | 28 | $2,240 | $703.89 | 31.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 37 | 37 | $2,035 | $700.04 | 34.4% |
About Dr. Donald Carney, M.D
Dr. Donald Carney, M.D is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932104932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Carney, M.D has received a total of $5,187 in payments from pharmaceutical and medical device companies, with $249.12 received in 2024. These payments were reported across 339 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,182).
As a Medicare-enrolled provider, Carney has provided services to 10,858 Medicare beneficiaries, totaling 18,517 services with total Medicare billing of $580,201. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Athens, TX
- Active Since 06/16/2005
- Last Updated 10/16/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1932104932
Products in Payments
- FARXIGA (Drug) $450.56
- LINZESS (Drug) $296.68
- JANUVIA (Drug) $287.75
- Ozempic (Drug) $228.80
- EVENITY (Biological) $184.59
- PREVNAR 13 (Biological) $179.96
- XARELTO (Drug) $170.52
- Saxenda (Drug) $157.26
- XIFAXAN (Drug) $150.81
- Yupelri (Drug) $141.38
- Rybelsus (Drug) $134.29
- MOUNJARO (Drug) $125.00
- UBRELVY (Drug) $124.85
- VRAYLAR (Drug) $120.06
- Kerendia (Drug) $115.50
- Aimovig (Biological) $105.67
- Vascepa (Drug) $105.04
- JARDIANCE (Drug) $95.30
- ENTRESTO (Drug) $91.96
- BELSOMRA (Drug) $83.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681